Notice of Intent to Publish a Funding Opportunity Announcement for Metastasis Research Network (U54 Clinical Trial Not Allowed)

0
138

Opportunity ID: 325184
Opportunity Number: NOT-CA-20-028
Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for Metastasis Research Network (U54 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.393
93.394
93.395
93.396
93.399
Eligible Applicants: State governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Mar 05, 2020
Last Updated Date: Mar 05, 2020
Estimated Synopsis Post Date: Apr 15, 2020
Fiscal Year: 2021
Award Ceiling: $1,500,000
Award Floor:
Estimated Total Program Funding: $7,500,000
Expected Number of Awards: 5
Description: The National Cancer Institute (NCI) intends to publish a Funding Opportunity Announcement (FOA) as a Request for Application (RFA) to solicit applications to build the Metastasis Research Network. This Notice is being provided to allow potential applicants time to develop responsive projects and meaningful collaborations. The FOA is expected to be published in April 2020 with expected application due dates in Summer 2020 and Winter 2021. The FOA will use the U54 activity code (Clinical Trial Not Allowed). Details of the planned FOAs are provided below.
Version: 1





Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for Metastasis Research Network (U54 Clinical Trial Not Allowed)